Pharma Company Agrees To Pay Up To $50M In FCA Suit Over Medicaid Rebate Dispute
WASHINGTON, D.C. — The U.S. Department of Justice (DOJ) announced that Nostrum Laboratories Inc. and its CEO and founder, Nirmal Mulye, have agreed to pay a minimum of $3,825,000, and up...To view the full article, register now.
Already a subscriber? Click here to view full article